 |
| | | Executive Director's Message | | | COVID-19 will hasten change to new models of care | | As we look toward to the next phase in our response to COVID-19, I have been reflecting on the importance of the courage to take risks as a leadership attribute. We can all think of a time in our lives when we have hesitated, uncertain of the future, yet by moving forward we arrive at our destination wiser and more resilient.
The past few weeks have been especially challenging for those directly involved in patient care... |
| | | |
| |
| | | Fighting the cancer corner during COVID-19 | | | Victorian COVID-19 Cancer Network (VCCN) | | Since March this year, the VCCC has been working with Monash Partners Comprehensive Cancer Consortium (MPCCC) on a collaborative project known as the Victorian COVID-19 Cancer Network (VCCN). As a workforce-led initiative, this has provided an agile response to the rapidly evolving issues created by the pandemic which are affecting everything from treatment guidelines to staff wellbeing.
 |
| | | |
| |
| | | Strive with less stress | | | Who do you think you are? Overcoming imposter syndrome | | Imposter syndrome is a term used to describe the feelings of being a fraud or not up to the task. It is common in life to occasionally feel as though we are out of our depth. This can be a good thing and focuses our attention on learning and the productive ways that we can do better in the future. But imposter syndrome can present a roadblock to a bright career and in a workplace it may mean that some of the best ideas never see the light of day.
 |
| | | |
| |
| Upcoming Events |
|
| | | | | | | 3 SEPTEMBER, EDUCATIONAL WEBINAR CO-HOSTED BY MPCCC AND VCCC | | CLINICAL APPLICATION OF GENOMICS: A PRACTICAL GUIDE FOR ONCOLOGISTS |
|
|
| | | | |
| | | | | 7 SEPTEMBER, VCCC MONDAY LUNCH LIVESTREAM | | PROF DEAN LUSHER ON SOCIAL NETWORK ANALYSIS: THEORY, METHOD AND APPLICATION |
|
|
| | | | |
| | | | | 9 SEPTEMBER, VCCC GRAND ROUND BREAST CANCER | | PROFESSOR SARAH-JANE DAWSON, CIRCULATING TUMOUR DNA TO MONITOR THE COMPLEXITY OF CANCER |
|
|
| | | | |
| | | | | 11 SEPTEMBER, CANCER AND COVID-19 IN VICTORIA: CLINICAL TRIALS DURING A HEALTHCARE CRISIS | | A REVIEW OF HOW VICTORIAN CANCER CLINICAL TRIAL PARTICIPANTS HAVE BEEN IMPACTED BY THE PANDEMIC |
|
|
| | | | |
| | | | | COMMENCES 7 SEPT - 4 WEEK MOOC | | ENROL NOW: CANCER SURVIVORSHIP FOR PRIMARY CARE PRACTITIONERS, CPD POINTS AVAILABLE |
|
|
| | | | |
| | | | | 14 SEPTEMBER, VCCC MONDAY LUNCH LIVESTREAM | | A/PROF ARUN AZAD: CIRCULATING DNA + RNA: UNCOVERING THE MYSTERIES OF ADVANCED PROSTATE CANCER |
|
|
| | | | |
| | | | | 21 SEPTEMBER, VCCC MONDAY LUNCH LIVESTREAM | | DR DESIREE DICKERSON: IMPOSTER SYNDROME IN RESEARCH |
|
|
| | | | |
|
| |
| Education & Training |
|
| | | Nurses fast-track research skills with innovative educational program | | | VCCC Nurse-led Research Hub Partnership Post Program | | The VCCC Nurse-led Research Hub provides a learning environment where nurses have protected time to develop their research skills. This year, the Partnership Post Program was interrupted by the pandemic – requiring adaptation to new ways of communicating. “We really broke research down to the bare bones,” said Jessica Demajo from St Vincent’s Hospital. Pheobe Robertson, Palliative Care Nurse at Austin Health, Olivia Newton-John Cancer Wellness and Research Centre agreed, “I so loved this course. I would begin it again tomorrow.”
 |
| | | |
| |
| Spotlight on... |
|
| | | Dr Vanessa Siva Kumar, Genomics Curation Lead, Monash Health | | MPCCC Tech Talk: Strategies and challenges in clinical data curation
September 18, 1.00pm - 2.00pm | | | Genomic testing has been integral to progress in precision medicine in recent years. The increasing affordability and advancement of genomic sequencing technologies have driven therapeutic approaches based on genetic variants and specific biomarkers, particularly in oncology. Large-scale datasets generated from next-generation sequencing require the application of various strategies to enable identification of potential clinical targets. The approach is evidence-driven, with the aim of providing a comprehensive assessment of tumour markers allowing improved therapy selection and enhanced patient care. This talk will focus on the principles in the analysis and interpretation of genomic variants, with an overview of the challenges in delivering this aim. |
| | | |
| |
| VCCC August snapshot |
|
| | |  | 1391
Professional development event attendees. |
|
| |  | 25
Professional development events. |
|
|
| |
| | Victorian Comprehensive Cancer Centre members | | |
| |
|
| |
| |
| |
| If you wish to stop receive these emails please Unsubscribe. |
| |
| © 2017 Victorian Comprehensive Cancer Centre Pty Ltd. |
| |
